Annual Revenue
N/A
December 31, 2023
Summary
- SLRX annual revenue is not available.
Performance
SLRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- SLRX quarterly revenue is not available.
Performance
SLRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- SLRX TTM revenue is not available.
Performance
SLRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
SLRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
SLRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Salarius Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$1.84 M(-422.1%) | $0.00(-100.0%) |
| Jun 2021 | - | $571.40 K(-55.0%) | -$536.00 K(-494.4%) |
| Mar 2021 | - | $1.27 M(-133.8%) | $135.90 K(<-9900.0%) |
| Dec 2020 | - | -$3.75 M(-372.4%) | -$100.00(-100.0%) |
| Sep 2020 | - | $1.38 M(+10.9%) | $4.79 M(+11.7%) |
| Jun 2020 | - | $1.24 M(+9.8%) | $4.29 M(+8.8%) |
| Mar 2020 | - | $1.13 M(+9.1%) | $3.94 M(+35.3%) |
| Dec 2019 | $3.47 M(+313.4%) | $1.04 M(+18.7%) | $2.91 M(+42.9%) |
| Sep 2019 | - | $874.90 K(-2.3%) | $2.04 M(+44.1%) |
| Jun 2019 | - | $895.80 K(+753.1%) | $1.41 M(+85.1%) |
| Mar 2019 | - | $105.00 K(-35.6%) | $764.60 K(-8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $838.10 K(-34.2%) | $163.10 K(-35.0%) | $838.20 K(-12.5%) |
| Sep 2018 | - | $251.00 K(+2.2%) | $957.90 K(-14.5%) |
| Jun 2018 | - | $245.50 K(+37.5%) | $1.12 M(-7.4%) |
| Mar 2018 | - | $178.60 K(-36.8%) | $1.21 M(-5.0%) |
| Dec 2017 | $1.27 M(+26.1%) | $282.80 K(-31.6%) | $1.27 M(-1.2%) |
| Sep 2017 | - | $413.60 K(+23.3%) | $1.29 M(-12.6%) |
| Jun 2017 | - | $335.50 K(+38.4%) | $1.48 M(+17.8%) |
| Mar 2017 | - | $242.50 K(-18.9%) | $1.25 M(+24.0%) |
| Dec 2016 | $1.01 M | $298.90 K(-50.1%) | $1.01 M(+42.0%) |
| Sep 2016 | - | $599.10 K(+431.6%) | $711.80 K(+531.6%) |
| Jun 2016 | - | $112.70 K | $112.70 K |
FAQ
- What is the all time high annual revenue for Salarius Pharmaceuticals?
- What is the all time high quarterly revenue for Salarius Pharmaceuticals?
- What is the all time high TTM revenue for Salarius Pharmaceuticals?
What is the all time high annual revenue for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual revenue is $3.47 M
What is the all time high quarterly revenue for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly revenue is $1.38 M
What is the all time high TTM revenue for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high TTM revenue is $4.79 M